Please login to the form below

Not currently logged in
Email:
Password:

trial data

This page shows the latest trial data news and features for those working in and with pharma, biotech and healthcare.

CanSinoBIO considers booster jab for COVID-19 vaccine

CanSinoBIO considers booster jab for COVID-19 vaccine

Tao added that a booster dose is being considered, with trial participants potentially set to receive a second jab around six months after their first dose. ... Tao. He said, however, that further clinical trial data is required before the exact efficacy

Latest news

More from news
Approximately 45 fully matching, plus 769 partially matching documents found.

Latest Intelligence

  • A new era for UK-Japanese scientific research relations A new era for UK-Japanese scientific research relations

    These guidelines exist because, historically, some regions have had limited willingness to rely on foreign clinical data. ... Adopting these guidelines recognised procedures under which trial data gathered in one region could be used to fulfil regulatory

  • A cultural shift in clinical research A cultural shift in clinical research

    travel to investigative sites, as well as increased device integrations with consumer and medical data capture tools. ... Perennial encryption technology is used to protect the sensitive data being collected and shared with trial leaders.

  • Transforming clinical trial data into a long-term asset Transforming clinical trial data into a long-term asset

    Meanwhile, 65% of compliance, legal and regulatory professionals described their ability to access archived trial data as ‘extremely inadequate’ or ‘very inadequate’. ... Yet it seems that numerous archives of clinical trial data could be

  • Think fast, be different: succeeding at speed chess in 2021’s COVID-19 world Think fast, be different: succeeding at speed chess in 2021’s COVID-19 world

    Take a typical head-to-head study, for example. Most often, trial data is shown as a standard bar chart comparing each product on the key endpoints. ... EBCs can take a leadership role reaching HCPs in new and better ways through data visualisation.

  • The search for effective drug treatments for COVID-19 The search for effective drug treatments for COVID-19

    However, the data from the Solidarity trial does not negate other study results – particularly from a trial designed with the strictest of scientific standards and rigorous data collection, as is the ... The data was peer-reviewed and published in NEJM.

More from intelligence
Approximately 0 fully matching, plus 66 partially matching documents found.

Latest appointments

More from appointments
Approximately 0 fully matching, plus 4 partially matching documents found.

Latest from PMHub

More from PMHub
Approximately 1 fully matching, plus 31 partially matching documents found.

PMEA Awards 2020

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Hanover Communications

Healthcare is evolving rapidly. To stand out from the crowd requires a potent combination of rich insight, innovative ideas and...

Latest intelligence

3 tips to show patient diversity in your clinical trial materials
Here are some useful tips to help get your hands on authentically diverse stock photos....
01 PME-APR21 Cover.jpg
Virtual congresses: video thrilled the cardio tsar
Chris Ross explores the key learnings from a year of virtual congresses...
When Will We Be Back To Normal?
The definitive question of 2021, whether you’re a homeschooling parent, a homebound professional, a wanderer with nowhere to go… or all three at once....

Infographics